US officials announced Thursday that Endo Health Solutions agreed to pay around $2 billion to settle civil and criminal charges it mislabeled pain reliever drug Opana, which has contributed to the opioid epidemic.
US officials announced Thursday that Endo Health Solutions agreed to pay around $2 billion to settle civil and criminal charges it mislabeled pain reliever drug Opana, which has contributed to the opioid epidemic.